Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

NCT00373711 ·Status: WITHDRAWN

Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma

NCT02515084 ·Status: COMPLETED ·Phase: PHASE2

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

NCT03196518 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

NCT02856347 ·Status: COMPLETED ·Phase: NA

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

NCT04552847 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

NCT04258592 ·Status: TERMINATED ·Phase: PHASE1

Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.

NCT03555487 ·Status: COMPLETED ·Phase: PHASE3

Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer

NCT06167629 ·Status: RECRUITING

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

NCT00537797 ·Status: COMPLETED ·Phase: NA

Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT01179360 ·Status: COMPLETED

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

NCT06359795 ·Status: RECRUITING ·Phase: NA

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

NCT03051542 ·Status: UNKNOWN ·Phase: NA

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

NCT04809584 ·Status: APPROVED_FOR_MARKETING

Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer

NCT04008095 ·Status: COMPLETED

PET With [18F]HX4 in Head and Neck Cancer

NCT01347281 ·Status: COMPLETED ·Phase: NA

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

NCT06813742 ·Status: RECRUITING

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

NCT03883776 ·Status: COMPLETED ·Phase: PHASE1

68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer

NCT04831541 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy

NCT03741231 ·Status: COMPLETED

18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.

NCT02969564 ·Status: COMPLETED

Evaluation of the Metastasis and Recurrence of Prostate Cancer

NCT03507595 ·Status: UNKNOWN

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

NCT04161781 ·Status: COMPLETED

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

NCT05430841 ·Status: COMPLETED ·Phase: NA

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

NCT04510311 ·Status: COMPLETED ·Phase: EARLY_PHASE1